海创药业: 关于持股5%以上股东权益变动触及1%刻度的提示性公告

Group 1 - The announcement indicates that Chengdu Yingchuang Power Venture Capital Co., Ltd. has reduced its shareholding in Haichuang Pharmaceutical Co., Ltd. from 6.28% to 6.00%, a decrease of 0.28% [1][2] - The reduction in shareholding was executed through centralized bidding transactions, with a total of 276,133 shares sold [1] - The reduction has triggered a change in equity that touches the 1% threshold, but the overall reduction plan has not yet been fully implemented [1][2] Group 2 - The announcement confirms that the equity change does not violate any prior commitments or plans made by the shareholder [1] - The company has disclosed that there are no other shareholders acting in concert with Chengdu Yingchuang Power Venture Capital Co., Ltd. [1] - The specific details of the share reduction plan were previously disclosed on May 14, 2025, in a separate announcement [1]